CompaniesByCap
MDGL
Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ · Healthcare

Madrigal Pharmaceuticals, Inc. Cash Flow 2012–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Operating Activities
Operating Cash Flow-189.6M-455.6M-324.2M-224.9M-183.9M-157.6M-41.6M-25.5M-22.3M-17.6M
Depreciation & Amort.1.5M1.1M527,000467,000405,000471,000112,00096,00077,000156
Investing Activities
Capital Expenditure467,0001.5M1.5M217,000209,000334,000172,00022,000125,0003,000
Free Cash Flow-190.0M-457.0M-325.7M-225.1M-184.1M-157.9M-41.8M-25.5M-22.4M-17.6M
Financing Activities
Dividends Paid
Stock Buybacks

Madrigal Pharmaceuticals, Inc. Cash Flow — FAQ

Madrigal Pharmaceuticals, Inc. (MDGL) cash flow over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see MDGL's cash flow history?

The chart and table above show Madrigal Pharmaceuticals, Inc.'s cash flow by year and by quarter, including the growth rate.